WASHINGTON, Aug 19 (Reuters) - U.S. President Donald Trump on Wednesday touted the use of convalescent plasma as a treatment for COVID-19 and suggested a reported decision by regulators to put on hold an emergency authorization for its use could be politically motivated.
“I’ve heard fantastic things about convalescent plasma,” Trump told a briefing. “It could be a political decision,” he said.
Reporting by Andrea Shalal; Writing by Eric Beech; Editing by Mohammad Zargham
Our Standards: The Thomson Reuters Trust Principles.